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Dear Editor,
Hepatocellular carcinoma (HCC) is the fifth most 
common malignancy in the world and is estimated to 
cause  approximately  half  a  million  deaths  annually 
(1).  The  incidence  of  HCC  varies  widely  according  to 
geographic location. The distribution of HCC also 
differs  among  ethnic  groups  and  regions  within  the 
same country; the extreme difference in distribution of 
HCC isprobably due to regional variations in exposure 
to  different  risk  factor  such  as  hepatitis  viruses  and 
environmental pathogens (2). A variety of important 
risk factors for HCC development has been identified. It 
includes the hepatitis B carrier state, chronic hepatitis C 
virus (HCV) infection, hereditary hemochromatosis, and 
cirrhosis of almost any cause (3). I read valuable article 
of Darvish Moghaddam et al. (4) about incidence of HCC 
in southeast of Iran; it seems we need more discussion 
about risk factors in this region, particularly in Kerman 
province. They also said “It seems that the incidence of 
HCC is much higher in Kerman compared to other parts 
of Iran and some portion of the lower HCC incidence rate 
in Iran-as a whole than in Kerman-could be due to the low 
accuracy of the national cancer registry compared to the 
sensitivity of our multiple sources of active case findings 
in Kerman” but it seems that two major risk factor for 
HCC were forgotten and maybe the higher incidence of 
HCC in Kerman is due to higher prevalence of HBV and 
HCV infections not just for greater exposure to dietary 
aflatoxin in the past. Our available data on HBV and HCV 
infections in Iran (5, 6) shows that we have no data about 
these two major risk factors for HCC in Kerman province. 
In this way we can say we need more studies on HBV , HCV 
and other chronic liver diseases as a risk factor of HCC in 
Kerman province that could be helpful in public health 
management too.
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